Guilherme Baldo

In vivo genome editing of mucopolysaccharidosis I mice using the CRISPR/Cas9 system

Roselena Silvestri Schuh, Édina Poletto, Gabriela Pasqualim et al. · Journal of Controlled Release · 2018 · 68 citations

Knockout Mouse, Off-target Effect, Engineering +13

Enzyme replacement therapy started at birth improves outcome in difficult-to-treat organs in mucopolysaccharidosis I mice

Guilherme Baldo, Fabiana Quoos Mayer, Barbara Martinelli et al. · Molecular Genetics and Metabolism · 2013 · 58 citations

Translational Medicine, Enzyme Replacement Therapy, Pathology +4

Lysosomal diseases: Overview on current diagnosis and treatment

Fabiano de Oliveira Poswar, Filippo Pinto e Vairo, Maira Graeff Burin et al. · Genetics and Molecular Biology · 2019 · 55 citations · Full text

Protein Deficiencies, Enzyme Replacement Therapy, Genetics +18

Pathogenesis of aortic dilatation in mucopolysaccharidosis VII mice may involve complement activation

Guilherme Baldo, Susan Wu, Ruth A. Howe et al. · Molecular Genetics and Metabolism · 2011 · 48 citations

Inflammation, Complement System, Autoimmune Disease +11

Bone marrow derived cells decrease inflammation but not oxidative stress in an experimental model of acute myocardial infarction

Ângela Maria Vicente Tavares, Alex Sander da Rosa Araújo, Guilherme Baldo et al. · Life Sciences · 2010 · 45 citations